The CSL (ASX:CSL) share price is down 8% in the past month, here's why

This biotech giant's shares are having a rough few weeks…

| More on:
disappointed and sad woman

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price has been out of form in recent weeks.

So much so, the biotherapeutics giant's shares are down almost 8% since this time last month at $278.75.

This means the CSL's shares are now in negative territory year to date with a 2% decline.

Why is the CSL share price down 8% in a month?

Investors have been selling down the CSL share price over the last few weeks following the release of a couple of reasonably bearish broker notes.

One of those came from investment bank Citi towards the end of June. According to the note, the broker has downgraded the company's shares to a neutral rating with a $310.00 price target.

Its analysts made the move on valuation grounds, believing that its recovery was priced in on 23 June when the CSL share price was fetching ~$300.

Citi commented: "We move CSL to Neutral (from Buy) given the outperformance of the stock since March. We remain 15% ahead of consensus for FY23E, and believe that the plasma collection market will normalize this year. Our rating change is purely valuation based. Risk to the upside remains if the CSL112 phase III trial result due at the end of CY21 is positive."

What else happened?

Also weighing on the CSL share price was a similarly mixed note out of Credit Suisse released two days later. According to that note, the broker downgraded CSL's shares to a neutral rating and cut the price target on them to $310.00.

Credit Suisse warned that a short term de-rating of the company's shares could happen due to potential margin weakness in the near term caused by plasma collection headwinds. The broker is forecasting a gross margin of 54.1% for its CSL Behring business in FY 2022, down from 61.2% in FY 2020.

CSL is likely to provide guidance next month with its full year results release. All eyes will be on those margins.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A golfer celebrates a good shot at the tee, indicating success.
Share Market News

Here are the top 10 ASX 200 shares today

ASX investors finally enjoyed a win this Thursday...

Read more »

a man sits back from his laptop computer with both hands behind his head feeling happy to see the Brambles share price moving significantly higher today
Industrials Shares

Up 39% in a year, is there more growth to come for this ASX 200 share?

IML Equity Analyst Josh Freiman shares his views on a major ASX 200 industrial stock.

Read more »

Man looking at his grocery receipt, symbolising inflation.
Share Market News

What the latest US inflation print means for ASX 200 investors

The ASX 200 is likely to benefit if the US Fed cuts interest rates again in December. But will it?

Read more »

guy helping girl invest in shares and dividends
Opinions

5 ways for investors buying ASX shares to stay focused during economic uncertainty

AMP Chief Economist, Dr Shane Oliver, offers advice on how to handle the Trump factor.

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why Graincorp, Light & Wonder, Orica, and Wildcat shares are falling today

These shares are having a tough time on Thursday. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Catapult, Flight Centre, Nufarm, and Xero shares are storming higher today

These shares are having a strong session on Thursday. But why? Let's find out.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

1 ASX growth stock down 30% I'd buy right now

This international business is growing core earnings at a strong rate.

Read more »

Concept image of a man in a suit with his chest on fire.
Record Highs

How long can the CBA share price keep this up?

Australia's biggest bank is running hot. Does it make any sense?

Read more »